Your session is about to expire
← Back to Search
Texting Intervention (T-WRITE) for Aphasia (T-WRITE Trial)
N/A
Waitlist Available
Led By Leora Cherney, PhD
Research Sponsored by Shirley Ryan AbilityLab
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from pre-treatment to post-treatment (i.e. following completion of 36 hours of treatment at 4 weeks)
Awards & highlights
T-WRITE Trial Summary
Improving Electronic Written Communication in Aphasia
T-WRITE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from pre-treatment to post-treatment (i.e. following completion of 36 hours of treatment at 4 weeks)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from pre-treatment to post-treatment (i.e. following completion of 36 hours of treatment at 4 weeks)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Western Aphasia Battery-Revised (WAB-R) Writing subtest
Secondary outcome measures
Stroke and Aphasia Quality of Life Scale (SAQOL-39)
The Friendship Scale
T-WRITE Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Texting Intervention (T-WRITE)Experimental Treatment1 Intervention
Computer-based treatment targeting written language via texting (90 minutes a day, 5 days a week for 4 weeks)
Group II: HandWriting Intervention (ORLA+WTG)Active Control1 Intervention
Computer-based treatment targeting written language via handwriting (90 minutes a day, 5 days a week for 4 weeks)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Texting Intervention (T-WRITE)
2018
N/A
~70
Find a Location
Who is running the clinical trial?
Shirley Ryan AbilityLabLead Sponsor
194 Previous Clinical Trials
16,849 Total Patients Enrolled
9 Trials studying Aphasia
358 Patients Enrolled for Aphasia
James Madison UniversityOTHER
11 Previous Clinical Trials
1,613 Total Patients Enrolled
Leora Cherney, PhDPrincipal Investigator - Shirley Ryan AbilityLab
Shirley Ryan AbilityLab
2 Previous Clinical Trials
104 Total Patients Enrolled
2 Trials studying Aphasia
104 Patients Enrolled for Aphasia
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
Illinois
How old are they?
18 - 65
What site did they apply to?
Shirley Ryan AbilityLab
What portion of applicants met pre-screening criteria?
Met criteria
Share this study with friends
Copy Link
Messenger